Skip to main content

Table 5 Glycaemic control of various patient groups

From: Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol

Patient group

Blood glucose

 

4.4 to 6.1 mmol/l

6.2 to 7.99 mmol/l

All patients (n = 50)

23.1% (15.4 to 29.8)

48.5% (36.9 to 60.8)

Surgical patients (n = 19)

23.9% (14.4 to 31.0)

55.7% (40.6 to 63.9)

Medical patients (n = 31)

22.1% (16.7 to 29.8)

40.3% (30.0 to 56.6)

History of diabetes (n = 6)

11.6% (2.9 to 20.8)

36.3% (15.3 to 43.5)

No history of diabetes (n = 44)

23.9% (18.4 to 30.7)

51.6% (38.8 to 63.0)

Co-prescription of drug(s) causing hyperglycaemia (n = 32)

26.3% (19.0 to 30.7)

47.7% (37.8 to 59.7)

Co-prescription of drug(s) causing hypoglycaemia (n = 5)

7.0% (2.0 to 31.6)

62.8% (17.4 to 75.4)

  1. Shown are the percentages of the intensive insulin therapy course spent in the specified glycaemic ranges. Values are expressed as median (interquartile range).